Analyzing the Interplay: The Impact of Pandemics on Systemic Disease
At HBVS-PanCyBliver, based in Rome, Lazio, Italy, we are dedicated to shedding light on how cardiovascular, vascular, cerebrovascular, and neurological diseases have evolved in response to recent pandemics. Our commitment is to provide clear, actionable insights, helping you navigate these complex health challenges and empowering informed decisions. Explore how our research and expertise can contribute to a healthier future.
Your Questions, Our Insights
Our mission began with a profound observation: the world has changed, and so has the landscape of health. At HBVS-PanCyBliver, we are a healthcare organization dedicated to understanding these shifts. This section addresses your most pressing questions regarding the interconnectedness of pandemics and critical health conditions, offering perspectives rooted in our commitment to public awareness and proactive health management.
What are the most common questions regarding the impact of pandemics on cardiovascular, vascular, and neurological diseases?
Is my hypertension preventable or curable in its fundamental nature, beyond the stabilizing effects of antihypertensive medications
The answer is yes; however, it is a medium-term journey requiring at least three to four months—even for the most severe hypertensive presentations—and necessitates strict medical supervision.
When considering how pandemics might alter these diseases, what are the most common sources of confusion or concern?
Beyond the severe manifestations observed in older adults, many parents have been devastated by the high number of children and young adults—from Generation Z and the Millennial generation—who have suffered brain hemorrhages or fatal cardiac events following SARS-CoV-2 infection or its associated co-pathogens. These families have faced these tragic consequences without adequate support from stakeholders or organized healthcare systems capable of providing a proactive 'self-care shield' for their defense. Often, they were not even encouraged to take practical, preventive measures for their loved ones.
By educating families to recognize the symptoms of rapidly rising hypertension in both adults and children, we aim to provide patients with essential tools. These pivotal measures can be undertaken to manage such manifestations through a safe, innovative approach that is not strictly limited to traditional pharmacological schedules. We offer specific 'preventive diagnosis' insights for this younger demographic which, when combined with lifestyle adjustments, non-pharmacological interventions, or the use of certain over-the-counter options—such as cyproheptadine syrup (see the adjacent column)—can effectively guide at-risk individuals toward safety. Furthermore, guidance on supplementary treatments, lifestyle modifications, and sports to avoid (or approach with specific precautions) can significantly enhance parental awareness and protection.
We can reassure them: it is simply a matter of care and knowledge, consistent monitoring, and enhanced self-awareness among all family members.
What key insights do you believe are essential for the public to know about the post-pandemic shifts in these health conditions?
We aim to highlight essential information regarding how cysticercosis is typically acquired and transmitted within family or social circles, as well as the mechanisms of auto-reinfection. These processes no longer follow the slow pace of their natural evolution; instead, they now follow the significantly accelerated course triggered by recent pandemics.
Close attention must also be paid to specific accompanying symptoms.
For instance, a significant 'atopic cortege'—indicating a newly activated histaminergic system emerging from a previously asymptomatic history—serves as a critical warning sign.
Furthermore, the development of typical gastrointestinal manifestations, such as diarrhea or perianal pruritus, is highly pathognomonic.
Ideally, with proactive disease detection by both patients and clinicians, the focus should shift toward specific pathognomonic radiological examinations. A 3-Tesla head MRI, for instance—interpreted by an experienced physician or even reappraised by the patients themselves—can serve as a primary diagnostic tool. Both professionals and laypeople can readily compare their own imaging with our benchmark diagnostic cases (see 'Brain and Heart' on our blog), which provide a more sensitive and specific detection of cysticercosis. This approach currently offers greater reliability than laboratory diagnostics, which remain poorly standardized and in need of further refinement.
The fact that post-pandemic food contamination has increased—driven by higher circulating titers of pathogenic ova in crops, livestock, and agricultural environments—necessitates greater public awareness. Achieving these two milestones is aimed at:
Understanding the link between the pathogen and the resulting diseases;
Ensuring the early detection and measurement of initial contamination, while preventing or treating the subsequent medical conditions
What are the one or two key takeaways you want people to remember or feel more confident about after visiting this FAQ page?
The clinical manifestations of cysticercosis—whether in carriers or affected individuals—can vary significantly due to the potent interactions triggered by viral infections. These presentations range from fatal cerebral hemorrhages, sudden cardiac death, and myocardial infarction to strokes, severe refractory hypertension, and multiple sclerosis. Furthermore, developmental disorders, epilepsy in children and adolescents, and widespread arterial or venous thrombosis affecting cardiac, cerebral, or visceral districts may occur at any age.
The identification of these conditions through:
- A pathognomonic diagnostic exam, such as a 3-Tesla MRI (see images on our blog);
- Ex-juvantibus evidence, such as the rapid hypotensive effect of antihistamines;
- Ex-nocentibus evidence, such as acute hypertensive or prothrombotic responses to mast-cell degranulating agents;
should not be a cause for alarm. Numerous pharmacological and non-pharmacological interventions can substantially halt, reverse, or even eradicate the disease, provided there is a timely diagnosis—particularly when clinical manifestations first arise, regardless of the patient's age. Most importantly, awareness of the disease allows for the implementation of lifestyle, non-pharmacological, and pharmaceutical solutions that can effectively counteract and revert even severe pathological progressions.
It is a formidable challenge, but together—as physicians and individuals—we can succeed.
"We cannot speak highly enough of the outstanding service we received from your team. You went above and beyond to address our needs, consistently exceeding our expectations."
Dennis T. & Teresa D.A.
"Swift solutions and unsurpassed medical perspectives have significantly benefited my cardiovascular health and addressed other family health issues, thanks to the truly innovative insights I gathered at HBVS-PanCyBliver.
I must admit these findings were entirely new to us, despite my direct access to cardiologists and neurologists within my own family"
Teodoro M.
"You can present them with a challenge, and they will resolve it. It is not a question of if, but when—they will succeed. You can place your absolute trust in them, even entrusting them with your life and health. They possess extraordinary resources to succeed exactly where others have failed."
Corrado M. & Pompeo Giuseppe C.
Testimonials
"I wish I had become aware of their proposed solutions and discoveries sooner. Despite being a physician with access to many specialized colleagues and professors, I believe that had HBVS-PanCyBliver been available earlier, many of my family's health issues could have been resolved much more quickly. Timely access to their insights can truly transform a patient’s health trajectory."
Paola Pescosolido
"As a primary care physician,
I can personally attest to the validity of the pathophysiological and therapeutic considerations they so compellingly propose and defend.
Many of my patients have experienced unexpected and significant benefits by following their clinical indications."
Cesare Zuchegna
"Having practiced as a neurologist for several decades, I have been deeply struck by the results of their research. Although their findings surpassed anything I had previously envisioned,
I have found them of extraordinary power and value, successfully integrating them into my own clinical practice."
Roberto Tramutoli
The insights I gained from their work have been pivotal in my daily medical practice,
particularly when managing frail, immunocompromised, and multi-comorbid patients suffering from complex cardiovascular and neurological conditions.
I strongly encourage my colleagues to stay updated on their ongoing research and future clinical developments
Stefano Ronzoni
"Their suggestions came when I least expected them, providing powerful and effective support throughout my extensive health journey. Unexpectedly, their team reached a milestone I had been awaiting for decades. They far surpass current standards, meeting our needs and consistently exceeding our expectations"
An actively hoping individual
Empowering Your Health Decisions
This is where knowledge transforms into action. At HBVS-PanCyBliver, we believe in providing insights that drive better health outcomes, particularly concerning the complex interplay between pandemics and chronic diseases. Join us in our mission to understand, prevent, and manage these conditions. We are dedicated to your well-being and stand ready to support you